Eyepoint Pharmaceuticals on Wednesday reported a loss of $34.4 million in its fiscal fourth quarter.
This Week’s Poll
- Linear Retail Acquires Newton Retail Portfolio
- Bank Executive and Husband Sentenced After Embezzling $2.7M
- Masonic Building Reborn as Apartments in Malden
- Former State Street Executive Sentenced for Secret Trading Commissions Scheme
- Trillium Brewing Eyes Beer Hall at Former Reebok Campus